Emerging horizons in cancer therapy: Squamous transition drives drug resistance

Ningxia Zhang , Xinyuan Tong , Hongbin Ji

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1697

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1697 DOI: 10.1002/ctm2.1697
COMMENTARY

Emerging horizons in cancer therapy: Squamous transition drives drug resistance

Author information +
History +
PDF

Abstract

• Adeno-to-squamous transition (AST) drives targeted therapy resistance.

• Progressive plasticity is acquired during Adeno-to-squamous transition (AST).

Keywords

Adeno-to-squamous transition (AST) / Drug Resistance / Targeted Therapy

Cite this article

Download citation ▾
Ningxia Zhang, Xinyuan Tong, Hongbin Ji. Emerging horizons in cancer therapy: Squamous transition drives drug resistance. Clinical and Translational Medicine, 2024, 14(6): e1697 DOI:10.1002/ctm2.1697

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AwadMM, LiuS, RybkinII, et al. Acquired resistance to KRAS(G12C) inhibition in cancer. N Engl J Med. 2021;384(25):2382-2393.

[2]

TongX, PatelAS, KimE, et al. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer Cell. 2024;42(3):413-428. e7.

[3]

SchoenfeldAJ, ChanJM, KubotaD, et al. Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line Osimertinib in EGFR-mutant lung cancer. Clin Cancer Res. 2020;26(11):2654-2663.

[4]

QinZ, YueM, TangS, et al. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. J Exp Med. 2024;221(3):e20232028.

[5]

FangZ, HanX, ChenY, et al. Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation. Signal Transduct Target Ther. 2023;8(1):16.

[6]

HanX, LiF, FangZ, et al. Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma. Nat Commun. 2014;5:3261.

[7]

TangS, XueY, QinZ, et al. Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment. Natl Sci Rev. 2023;10(4):nwad028.

[8]

LiF, HanX, LiF, et al. LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response. Cancer Cell. 2015;27(5):698-711.

[9]

WangM, ChenX, TanP, et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2022;40(9):1044-1059.e8.

[10]

MoormanA, Cambuli F, BenitezEK, et al. Progressive plasticity during colorectal cancer metastasis. bioRxiv. 2023. 2023.08.18.553925.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

154

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/